Hemophilia Federation of America is a national nonprofit organization that assists, educates, and advocates for the bleeding disorders community.
Note: the following is the edited form of a press releaseoriginally published by uniQure. The full release can be read here. On Thursday, January 7, 2016, uniQure N.V. announced preliminary topline results from the low-dose cohort of an ongoing Phase I/II clinical trial being conducted in adult hemophilia B patients treated with uniQure’s novel AAV5/FIX […]
Sign up for E-mails, Dateline Magazine, and other ways to stay connected.